DMTK(Delisted)
DermTechยทNASDAQ
--
--(--)
DMTK Profile
Dermtech, Inc.
A leading developer of non-invasive gene expression tests for skin health and cancer diagnosis
12340 El Camino Real, San Diego, CA 92130
--
DermTech, Inc., which was incorporated on July 31, 2015, completed its merger in Delaware, USA on August 29, 2019. The company is a molecular diagnostic company that develops and markets novel non-invasive genomics tests to help diagnose and manage skin cancer, inflammatory skin diseases and skin diseases associated with aging. The company's technology enhances the detection of early melanomas by non-invasive detection of genomic markers associated with melanomas, thereby identifying higher-risk lesions at an early stage, thereby excluding melanomas with more than 99% negative predictive values.
